Logo

Affy to Request Hearing After Nasdaq Says Firm Is Not in Compliance

Aug 18, 2006
NEW YORK (GenomeWeb News) - Affymetrix said yesterday it would request a hearing after the Nasdaq Exchange said the company was not in compliance with the requirements to remain listed on the exchange.
 
As expected, the Nasdaq issued Affy a letter warning of its possible delisting after the company filed its second quarter financial results late.
 
Affymetrix shares will remain listed on the Nasdaq stock market until the Listing Qualifications Panel makes a decision.
Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.